Caris Life Sciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-276.1M | $-298.4M | $22.3M | $15.2M |
| FY2024 | $-245.2M | $-253.6M | $8.4M | $18.6M |
| FY2025 | $83.2M | $66.9M | $16.3M | $70.0M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-276.1M | $-298.4M | $22.3M | $15.2M |
| FY2024 | $-245.2M | $-253.6M | $8.4M | $18.6M |
| FY2025 | $83.2M | $66.9M | $16.3M | $70.0M |